Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Thalidomide (Antileprotic)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Talidex 25mg tablets
0501100J0BCAAAJ
|
Talidex | Thalidomide (Antileprotic) | Infections | No data available |
|
Thalidomide 100mg tablets
0501100J0AAAAAA
|
Thalidomide (Antileprotic) | Thalidomide (Antileprotic) | Infections | No data available |
|
Thalidomide 25mg tablets
0501100J0AAAJAJ
|
Thalidomide (Antileprotic) | Thalidomide (Antileprotic) | Infections | No data available |
|
Thalidomide 50mg tablets
0501100J0AAAIAI
|
Thalidomide (Antileprotic) | Thalidomide (Antileprotic) | Infections | No data available |
|
Thalidomide 50mg/5ml oral liquid
0501100J0AAAHAH
|
Thalidomide (Antileprotic) | Thalidomide (Antileprotic) | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.